Quantcast

Latest pharmaceutical industry Stories

2014-10-28 08:34:41

COSTA MESA, Calif., Oct. 28, 2014 /PRNewswire-iReach/ -- WCCT Global, a full Service Contract Research Organization headquartered in Southern California announced their involvement in a sentinel clinical trial designed to evaluate safety and immunogenicity signals from a novel oral vaccine for influenza, as opposed to injectable or intranasal vaccines. The study was first presented to the scientific community on October 14, 2014 at the World Vaccine Congress in Brussels, Belgium by...

2014-10-28 08:33:41

LOS ANGELES and SHANGHAI, Oct. 28. 2014 /PRNewswire/ -- The generation of high-resolution pictures of hundreds of medically important proteins known as G-protein coupled receptors (GPCRs) will be the goal of an ambitious new international partnership. Called the GPCR Consortium, this non-profit initiative brings together major pharmaceutical companies and leading research institutes from three continents to advance GPCR research for drug development. The human body is controlled by...

2014-10-28 04:22:32

PARIS, October 27, 2014 /PRNewswire/ -- Sanofi, a global and diversified healthcare leader, reports results for the third-quarter of 2014. Jerome Contamine, Chief Financial Officer of Sanofi, comments on results and full year guidance. Watch video interview and read transcript: http://www.eurobusinessmedia.com/ceo-direct/sanofi/interview-with-cfo-jerome-contamine-q3-2014-results,2014-10-27,1292?utm_source=ceo-direct&utm_medium=wire Topics covered in...

2014-10-27 23:10:32

The FDA's enforcement plan makes it clear: Developing a successful CAPA program has never been more important. FDAnews and Compliance Media, Inc. are offering an advanced version of their previous CAPA investigations class, fully updated to meet tough FDA scrutiny in 2014. Falls Church, VA (PRWEB) October 27, 2014 Conducting Advanced Root Cause Analysis and CAPA Investigations Understanding Advanced Critical Thinking Skills and Innovative Techniques to Improve the Quality of...

2014-10-27 20:22:50

INDIANAPOLIS, Oct. 27, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) issued the following statement today in response to a judge's ruling that the punitive damages awarded in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al, No. 6:12-cv-00064 be reduced. The judge in the Louisiana multidistrict litigation trial reduced the punitive damages from $3 billion for Lilly and $6 billion for Takeda to $9.2 million for Lilly and $27.6 million for...

2014-10-27 16:27:26

Innovative software uses genetic information to find the best treatment options for cancer patients HOUSTON, Oct. 27, 2014 /PRNewswire/ -- Today, MolecularMatch, Inc. announced it has launched its innovative software solution as an open Beta information service for oncologists and patients to easily connect cancer patients with the most appropriate FDA-approved treatments and clinical trials based on the molecular make-up of the patient's disease....

2014-10-27 08:30:53

Ferrer Purchases $8 Million of Alexza Common Stock through New Investment and Elimination of Potential Milestone Payments MOUNTAIN VIEW, Calif. and BARCELONA, Spain, Oct. 27, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Grupo Ferrer Internacional, S.A. (Ferrer) announced today that they have amended their agreement for ADASUVE(®) (Staccato(®) loxapine). Ferrer is Alexza's commercial partner for ADASUVE in the European Union, Latin America and the...

2014-10-27 08:27:57

Addition of Respected Clinical Trials Company Expands MPI Research Capabilities to Include Human Phase I Testing MATTAWAN, Mich., Oct. 27, 2014 /PRNewswire/ -- MPI Research today announced it has acquired the assets of Kalamazoo, Mich.-based Jasper Clinical Research & Development, Inc. Jasper is a respected clinical research organization that provides early-stage human clinical testing of promising new drugs, and is well known to pharmaceutical and biotechnology companies...

2014-10-25 23:00:42

He will lead all research and development for the firm’s algae proteins used in human pharmaceuticals and specialty animal feed products. San Diego, CA (PRWEB) October 25, 2014 Triton Algae Innovations, a pioneer in synthetic biology, today announced Dr. Xun Wang has joined the firm as President and Director of all Research & Development. Triton has developed a patented synthetic biology platform for the production of high value algae-based proteins. According to Dr. Wang, the...

2014-10-24 08:26:28

Company Name Officially Changes from Access Pharmaceuticals, Inc. to PlasmaTech Biopharmaceuticals, Inc. DALLAS and NEW YORK, Oct. 24, 2014 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc. (OTCQB: ACCPD), formerly Access Pharmaceuticals, Inc. (ACCP), a biopharmaceutical company advancing patient care in critical areas, announced it has implemented a 1-for-50 reverse split of its common stock effective at the opening of trading on Friday, October 24, 2014. PlasmaTech's common stock...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related